Gland Pharma gets approval for Sugammadex Injection

Gland Pharma gets approval for Sugammadex Injection. The company received regulatory approval for Sugammadex Injection in two strengths: 200 mg/2 mL and 500 mg/5 mL, both as single-dose vials. This expansion enhances its anaesthesia portfolio and strengthens market positioning in the injectables segment. Approval could drive future revenue via market entry or partnerships.

📊 STOCKS: $GLAND | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma